anxiety

shutterstock_177126911

Introduction

Anxiety is something we can all relate to. For the most part, anxiety represents a healthy and adaptive physiological response to feared stimuli, preparing your body to respond accordingly. Perfect if you a™re being chased by a bear. However, it can be problematic if those feared stimuli are benign, no longer present, or constitute persistent worries about the future.

At it™s most debilitating, anxiety can be classified into a range of psychiatric diagnoses. The most common of these is generalised anxiety disorder (GAD), which has an estimated lifetime prevalence in the UK of between 4-7%. GAD is characterised by a range of physical symptoms such as muscle tension, poor concentration and disturbed sleep, as well as psychological symptoms such as ongoing and uncontrollable worry. Diagnoses such as panic disorder, social anxiety disorder and phobias all feature anxiety as a primary symptom. In total, anxiety-related difficulties have been estimated to affect as many as 18% of a US-based adult population over a 12-month period.

Though previously categorised as anxiety disorders, both obsessive compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are increasingly being understood as separate diagnoses, but again with anxiety as a common symptom.

What we know already

People with long-term physical health conditions are more prone to experience anxiety as a result. For example, it is estimated that people with Chronic Obstructive Pulmonary Disease (COPD) are up to 10 times more likely to receive a diagnosis of panic disorder than the general population. This, in turn, has considerable implications on healthcare expenditure.

Psychological treatments such a cognitive-behavioural therapy (CBT) have been widely researched and shown to be effective across a range of anxiety disorders. In the case of specific phobias, these techniques can elicit significant improvement in just one session. However, improvement rates are lower across other anxiety disorders.

In England, the National Institute for Health and Care Excellence (NICE) recommends CBT as the first line treatment of anxiety disorders. Pharmacotherapy, such as Sertraline, can also be beneficial, and is recommended as an adjunct to CBT where the person’™s difficulties are more severe.

Areas of uncertainty

Anxiety has been conceptualised in many ways, which in many ways have shaped the range of treatments available. This proliferation of cognitive, developmental, information-processing, neurochemical and other models of understanding anxiety can create a confusing picture. Similarly, whilst there is a clear hereditary component to anxiety, the precise nature is not yet clear.

Whilst psychological and pharmacological treatments can be effective for many, there is still work to be done in identifying the mechanisms of change and improving outcomes.

What’s in the pipeline?

Historically, research into anxiety disorders focused more heavily on adult populations. However, with the recent emergence of disciplines such as paediatric psychology, there is a greater emphasis on tackling anxiety difficulties at a younger age.

As our understanding of genetics improves, it is likely that we will discover more about the role of heritability in anxiety.

Perhaps, most importantly, given the effectiveness of treatments for anxiety, we should aim to reduce stigma and other barriers to access, to enable earlier intervention and better recovery.

References

Antony, M. M., and Stein, M. B. (2009). Oxford handbook of anxiety and related disorders. Oxford University Press. [Publisher]

Hoge, E. A., Ivkovic, A. and Fricchione, G. L. (2012). Generalized anxiety disorder: diagnosis and treatment. BMJ, 345. [Abstract]

Kesller, R. C., Ciu, W. T., Deler, O. and Walters, E. E. (2005). Prevalence, Severity, and Comorbidity of Twelve-month DSM-IV Disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry, 62, 617-627. [Abstract]

Naylor, C., Parsonage, M., McDaid, D., Knapp, M., Fossey, M. and Galea, A. (2012) Long-term conditions and mental health: the cost of co-morbidities. The King’s Fund, London, UK. [PDF]

Acknowledgement

Written by: Patrick Kennedy-Williams
Reviewed by:
Last updated: Sep 2015
Review due: Sep 2016

Our anxiety Blogs

Adult dental anxiety – management strategies

pablo-varela-vCfxXxbQRX8-unsplash

This review of current management strategies for adult patients with dental anxiety in the dental clinic included 54 studies. Most of the psychotherapeutic behavioural strategies provided some benefits but there was limited supporting evidence for some approaches. Pharmocological approaches were not included.

[read the full story...]

As waiting lists grow for anxiety disorders, should we be turning to digital interventions?

Featured

Theo Kyriacou and Andie Ashdown explore a recent systematic review that brings together two decades of research, which suggests that digital health interventions for anxiety disorders may be a more effective alternative to inactive controls, such as waiting-list groups.

[read the full story...]

Mindfulness in schools: MYRIAD trial findings offer limited support for school based mindfulness training

maxim-berg-h9sljx2r4Vk-unsplash

Lucinda Powell reports on the findings of the huge MYRIAD (My Resilience in Adolescence) project, which looked at the effectiveness of school based mindfulness training across more than 100 UK schools.

[read the full story...]

School based humanistic counselling: a little better than pastoral care, but more expensive

Male,College,Student,Meeting,With,Campus,Counselor,Discussing,Mental,Health

In her debut blog, Annie Stevenson reports on an RCT finding that school-based humanistic counselling reduces psychological distress, but is not cost-effective.

[read the full story...]

Depression and anxiety among doctors during the COVID-19 pandemic: yet more collateral damage?

cezar-sampaio-cFVuUj7Da20-unsplash

Eleana Frisira summarises a systematic review that presents recent global prevalence data about the rates of depression and anxiety among doctors during the COVID-19 pandemic.

[read the full story...]

Perinatal loss and mental health: are psychosocial interventions beneficial for parents?

sylwia-bartyzel-m7HrMJJ0bW0-unsplash

Jill Domoney explores a recent review, which suggests that psychosocial interventions may improve depression, anxiety, and grief amongst parents suffering from perinatal loss.

[read the full story...]

How important is understanding perfectionism for reducing depression and anxiety? #BABCP2022

Strive,For,Progress,,Not,Perfection,-,Handwriting,On,A,Napkin

Alice Potter considers a meta-synthesis of qualitative studies on the link between anxiety, depression, and perfectionism in young people, and the implications for treatment.

[read the full story...]

Experiences of junior doctors working during the pandemic in England

mulyadi-JeCNRxGLSp4-unsplash

Alejandro Arguelles Bullon summarises a qualitative study investigating the experiences of junior doctors in England during the Covid-19 pandemic.

[read the full story...]

Technology-based CBT for youth anxiety: moderate short-term benefits but uncertainty remains #CAMHScampfire

Young people with anxiety disorders may benefit from t-CBT in the short term.

Douglas Badenoch takes a look at a recent systematic review on technology-delivered CBT for anxiety disorders in children below 18 years of age.

Join us around the #CAMHScampfire on Tuesday 24th May to discuss this paper with the author and a group of experts.

[read the full story...]

Let’s group them together! Transdiagnostic group therapy for anxiety and depression

Featured

Melissa Black blogs an RCT which finds that transdiagnostic group therapy is not inferior to diagnosis specific CBT for anxiety and depression.

[read the full story...]